Endocrine News

Society News

Endocrine Society Scientific Statement Distinguishes Normal Aging from Endocrine Disease

A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention. “Hormones and Aging: An Endocrine Society Scientific Statement,” reviews the current state of research on hormonal...

Transgender Health

AMA Strengthens Policy on Protecting Access to Gender-affirming Care

The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to protect access to evidence-based gender-affirming care for transgender and gender-diverse individuals. The Endocrine Society partnered with the American Association of Clinical Endocrinology (AACE), the American Society for Reproductive Medicine (ASRM), and the Medical Student Section of the AMA House of...

ENDO Preview

Call to Action: Chérie L. Butts, PhD, Shares Her Career Path at ENDO 2023

Attendees at ENDO 2023 will have the opportunity to hear a unique perspective on a scientist’s career that flourished through academia, government, and industry. In her Meet the Scientist session, “A research career in government and industry, making sure drugs are safe and meaningful,” Cherie L. Butts, PhD, will not only detail her own career,...

ENDO Preview

Setting the Tone for Endocrinology’s Future Path

The upheaval of the COVID-19 pandemic led many of us to rethink aspects of our lives. At the Endocrine Society, this period gave us the chance to rethink many of our traditional approaches. While we are proud of the Society’s storied history, we balance that with continually thinking of new ways to serve you and...

ENDO Preview

Full Circle: Q&A with R. Scott Struthers, PhD, the Endocrine Society’s 2023 John D. Baxter Prize for Entrepreneurship Recipient

As the recipient of the 2023 John D. Baxter Prize for Entrepreneurship, R. Scott Struthers, PhD, talks to Endocrine News about his life’s work seeking therapies to cure endocrine diseases, the progress of some of the current treatments in development, and how industry is strikingly similar to academia. Sometimes life comes in full circles. It...

Ali Wins Wayne Bardin International Travel Award

The Endocrine Society selected Dalal S. Ali, MD, as the recipient of its 2023 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and research contributions related to bone disease, calcium, and endocrine disorders in pregnancy. Ali is a clinical fellow in metabolic bone disease at McMaster University in Hamilton, Ontario, Canada,...

Tirzepatide Safe and Tolerable in Treatment of Type 2 Diabetes, Researchers Find

Tirzepatide – the dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) injection used to treat type 2 diabetes – is safe and has a tolerable adverse event (AE) profile in its role in the management of T2D, and possibly obesity, according to a study recently published in the Journal of the...

Such Great Heights

Pediatric growth hormone deficiency treatments could soon be painless. Fernando Cassorla, MD, is traveling from Chile to Chicago to present research at ENDO 2023 that could potentially change the way pediatric hormone treatments are administered. If a pill could replace painful injections, patients and caregivers alike can finally wipe away their tears. A convenient, well...

Endocrine news on twitter